{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:55:22Z","timestamp":1775832922047,"version":"3.50.1"},"posted":{"date-parts":[[2026,4,10]]},"group-title":"In Review","reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,9]]},"abstract":"<title>Abstract<\/title>\n                <p>Genome-wide association studies have mapped hundreds of autoimmune risk loci, yet fewer than 5% of associated variants have established causal mechanisms. CTCF-bound insulators partition the genome into regulatory domains. When disrupted, enhancers can activate genes they normally do not regulate, a phenomenon termed insulator leakage that has been implicated in malignancy and may contribute to autoimmunity. We reasoned that prioritizing variants by predicted insulator disruption, then validating that prioritization empirically across independent cohorts and diseases, would yield candidates suitable for functional follow-up and target selection.\nInsulatorLeak combines SuSiE fine-mapping, Enformer-predicted CTCF disruption (Scaled Average Difference, SAD), locus-matched null calibration for empirical p-values, chromatin enrichment (ChromHMM, Hi-C), eQTL and pQTL colocalization, and benchmarking against FUMA, Sei, and Boltz-2. We applied the pipeline to 14 non-MHC autoimmune loci across seven diseases (multiple sclerosis, inflammatory bowel disease, rheumatoid arthritis, type 1 diabetes, systemic lupus erythematosus, psoriasis, and atopic dermatitis) using 19 GWAS datasets spanning more than 2.5 million total participants.\nIn MS, TNFRSF1A replicated in 4\/6 cohorts (p\u2009=\u20090.022), and IL2RA reached p\u2009=\u20090.006 in IMSGC MS Chip (N\u2009=\u2009115,803). Pan-autoimmune replication across seven diseases showed IL7R in 6\/7 expansion cohorts (p\u2009=\u20090.011\u20130.052) and TNFRSF1A in 5\/7 (p\u2009=\u20090.011\u20130.033), indicating insulator disruption as a shared autoimmune mechanism. Thirteen of 14 loci replicated in at least two ancestry groups. IL12AB was significant in all four ancestries, and TYK2 reached FDR q\u2009=\u20090.040 in South Asian. Chromatin enrichment was strongest at drug-target loci (CD58 21\u00d7, IL2RA 23\u00d7, IL7R 12\u00d7, TNFRSF1A 5.3\u00d7 in MS, CD40 8.6\u00d7 and IL7R 34\u00d7 in IBD). pQTL colocalization yielded cognate validation at CD58 (0.996), CD40 (0.958), CD6 (0.79 in IBD), and IL2RA (0.79). Both MS and IBD showed the full validation stack from fine-mapping through pQTL. Overlap with FUMA lead SNPs was 2\/120, indicating complementary rather than redundant prioritization. In RA, four loci reached p\u2009&lt;\u20090.05 (CLEC16A, TNFRSF1A, STAT3, BACH2). Extension to T1D, SLE, psoriasis, and AD is reported in Supplementary Table S8.\nIn a disease-specific locus extension (GAIM; General Autoimmune Insulator Mechanism) we applied the identical pipeline (SuSiE, Enformer CTCF SAD, and locus-matched nulls drawn from each indication\u2019s own GWAS) to fourteen top non-MHC loci per disease for five large-summary-statistic cohorts: atopic dermatitis meta-analysis (AD), T1D (Chiou et al. 2021), RA (FinnGen), IBD (de Lange et al. 2017), and SLE (Bentham et al. 2015). This tests insulator disruption at regions prioritized by each disease, not only at the MS-derived 14 locus set. Supplementary Table S15 lists, for every locus\u2013cohort pair, the minimum empirical p-value, Benjamini\u2013Hochberg q-value, variant identifier, and variant count. Representative indication-native signals include IL33 and STAT6 (AD), CCR7 and CTLA4 (T1D), TNFAIP3 (RA and SLE), RGS14 and TNFSF15 (IBD), and ITGAM (SLE). Full data are in Supplementary Table S15.\nInsulatorLeak produces mechanism-first target validation with empirical prioritization across autoimmune diseases. The pipeline generalizes from MS to six additional diseases. Loci corresponding to approved therapeutics (IL12AB\/ustekinumab, TYK2\/deucravacitinib, TNFRSF1A\/etanercept, IL2RA\/daclizumab) show consistent insulator-disruption signal, aligning mechanism-first prioritization with known drug targets. At shared loci, multiple diseases exhibit insulator disruption with disease-specific credible sets, consistent with insulator disruption as a general autoimmune mechanism at shared loci rather than transfer of MS-specific variants. The modular design permits application to other complex traits. Code is available upon request.<\/p>","DOI":"10.21203\/rs.3.rs-9368949\/v1","type":"posted-content","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:07:38Z","timestamp":1775830058000},"source":"Crossref","is-referenced-by-count":0,"title":["InsulatorLeak, a mechanism-first pipeline for variant prioritization by predicted CTCF insulator disruption across seven autoimmune diseases"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8018-2161","authenticated-orcid":false,"given":"Navya","family":"Shah","sequence":"first","affiliation":[{"name":"Karmyx BioLabs"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"10","key":"ref1","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/s41592-021-01252-x","article-title":"Effective gene expression prediction from sequence by integrating long-range interactions","volume":"18","author":"Avsec \u017d","year":"2021","unstructured":"Avsec \u017d et al (2021) Effective gene expression prediction from sequence by integrating long-range interactions. Nat Methods 18(10):1196\u20131203","journal-title":"Nat Methods"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Chiou J","year":"2021","unstructured":"Chiou J et al (2021) Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes. Nat Genet 53(7):962\u2013971","journal-title":"Nat Genet"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cell.2014.09.030","article-title":"Control of cell identity genes occurs in insulated neighborhoods in mammalian genomes","volume":"159","author":"Dowen JM","year":"2014","unstructured":"Dowen JM et al (2014) Control of cell identity genes occurs in insulated neighborhoods in mammalian genomes. Cell 159(2):374\u2013387","journal-title":"Cell"},{"issue":"7584","key":"ref4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature16490","article-title":"Insulator dysfunction and oncogene activation in IDH mutant gliomas","volume":"529","author":"Flavahan WA","year":"2016","unstructured":"Flavahan WA et al (2016) Insulator dysfunction and oncogene activation in IDH mutant gliomas. Nature 529(7584):110\u2013114","journal-title":"Nature"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei C","year":"2014","unstructured":"Giambartolomei C et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLOS Genet 10(5):e1004383","journal-title":"PLOS Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.16.25320672","article-title":"Genetic determinants of Multiple Sclerosis susceptibility in diverse ancestral backgrounds","author":"Jacobs BM","year":"2025","unstructured":"Jacobs BM et al (2025) Genetic determinants of Multiple Sclerosis susceptibility in diverse ancestral backgrounds. medRxiv. https:\/\/doi.org\/10.1101\/2025.01.16.25320672","journal-title":"medRxiv"},{"issue":"6460","key":"ref7","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","author":"IMSGC","year":"2019","unstructured":"IMSGC (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365(6460):eaav7188","journal-title":"Science"},{"issue":"2","key":"ref8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41588-018-0322-6","article-title":"GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals","volume":"51","author":"Iotchkova V","year":"2019","unstructured":"Iotchkova V et al (2019) GARFIELD classifies disease-relevant genomic features through integration of functional annotations with association signals. Nat Genet 51(2):343\u2013353","journal-title":"Nat Genet"},{"issue":"7944","key":"ref9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki MI","year":"2023","unstructured":"Kurki MI et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508\u2013518","journal-title":"Nature"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/ng.3359","article-title":"Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations","volume":"47","author":"Liu JZ","year":"2015","unstructured":"Liu JZ et al (2015) Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47(9):979\u2013986","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58310-7","article-title":"Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitis","author":"Riley-Gillis B","year":"2025","unstructured":"Riley-Gillis B et al (2025) Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitis. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-025-58310-7","journal-title":"Nat Commun"},{"issue":"7359","key":"ref12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer S","year":"2011","unstructured":"Sawcer S et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476(7359):214\u2013219","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56719-8","article-title":"GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets","author":"Stuart PE","year":"2025","unstructured":"Stuart PE et al (2025) GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targets. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-025-56719-8","journal-title":"Nat Commun"},{"issue":"7982","key":"ref14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","article-title":"Plasma proteomic associations with genetics and health in the UK Biobank","volume":"622","author":"Sun BB","year":"2023","unstructured":"Sun BB et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622(7982):329\u2013338","journal-title":"Nature"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/rssb.12388","article-title":"A simple new approach to variable selection in regression, with application to genetic fine mapping","volume":"82","author":"Wang G","year":"2020","unstructured":"Wang G et al (2020) A simple new approach to variable selection in regression, with application to genetic fine mapping. J R Stat Soc Ser B 82(5):1273\u20131300","journal-title":"J R Stat Soc Ser B"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","article-title":"Functional mapping and annotation of genetic associations with FUMA","volume":"8","author":"Watanabe K","year":"2017","unstructured":"Watanabe K et al (2017) Functional mapping and annotation of genetic associations with FUMA. Nat Commun 8:1826","journal-title":"Nat Commun"},{"issue":"6","key":"ref17","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2018.09.022","article-title":"Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression","volume":"175","author":"Schmiedel BJ","year":"2018","unstructured":"\u2022 Schmiedel BJ, Singh D, Madrigal A et al (2018) Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression. Cell 175(6):1701\u20131715e16. 10.1016\/j.cell.2018.09.022","journal-title":"Cell"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41588-022-01056-5","article-title":"Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells","volume":"54","author":"Ulirsch JC","year":"2022","unstructured":"\u2022 Ulirsch JC et al (2022) Prioritization of autoimmune disease-associated genetic variants that perturb regulatory element activity in T cells. Nat Genet 54(5):603\u2013612","journal-title":"Nat Genet"},{"key":"ref19","article-title":"Evidence for enhancer activity in intron 1 of TNFRSF1A using CRISPR\/Cas9 in human induced pluripotent stem cell-derived macrophages","volume":"15","author":"Thacker JS","year":"2025","unstructured":"\u2022 Thacker JS et al (2025) Evidence for enhancer activity in intron 1 of TNFRSF1A using CRISPR\/Cas9 in human induced pluripotent stem cell-derived macrophages. Sci Rep. ;15:s41598-025-18077-9.","journal-title":"Sci Rep"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9368949\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9368949\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T14:07:46Z","timestamp":1775830066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-9368949\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":19,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-9368949\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,4,10]]},"subtype":"preprint"}}